Virologic and Immunologic Outcomes after 24 Weeks in HIV Type 1–Infected Adolescents Receiving Highly Active Antiretroviral TherapyPatricia M. Flynn, Jane C. Lindsey, Stephen A. Spector et al.|The Journal of Infectious Diseases|2004Cited by 101
Long-Term Observation of Adolescents Initiating HAART Therapy: Three-Year Follow-UpPatricia M. Flynn, Elizabeth Smith, Jaime Martinez et al.|AIDS Research and Human Retroviruses|2007Cited by 65
Immune Reconstitution and Predictors of Virologic Failure in Adolescents Infected through Risk Behaviors and Initiating HAART: Week 60 Results from the PACTG 381 CohortBret J. Rudy, Steven D. Douglas, Patricia M. Flynn et al.|AIDS Research and Human Retroviruses|2006Cited by 35